Keytruda®, Ozempic® and the other blockbuster drugs of the 3rd quarter of 2019

The pharmaceutical companies AbbVie and Novo Nordisk presented their quarterly results today and concluded the earnings season for the major pharmaceutical companies. There are currently more than 50 blockbuster drugs in the world with annual sales exceeding a billion US dollars. Here the best selling and fastest growing medications of the third quarter of 2019 …

Diabetes and the third quarter of 2019

Novo Nordisk and Eli Lilly have both reported their Q3 results. Below are some of the headlines related to their diabetes business. Novo Nordisk OG2023SC, an oral GLP-1 analogue, has been discontinued based on encouraging results for an enhanced oral semaglutide formulation. US FDA decision on cardiovascular indication for Rybelsus® is expected in the first …

Kraft Heinz increases prices but experiences negative organic growth of -1.1%

Kraft Heinz issued a press release on its third quarter results before the market opened. Organic growth was -1.6% in the US and -1.1% for the whole business. Revenue and income by geographic and product segment Revenue growth was impacted negatively by negative organic growth, currency headwinds and divestitures. The natural cheese business being sold …

AB InBev increases prices in South Korea and Brazil and sees volume decline

AB InBev issued a press release on their quarterly results before the market opened. The two most important headlines of the quarter were probably the listing of Budweiser APAC on the HKEx and implementation of price increases in South Korea and Brazil that drove volume declines. Whereas revenue and revenue per hectolitre were up, volume …

Amazon operating income drops and AWS margins contract

Amazon issued a press release on their third quarter results after the market closed. Revenue increased by 24% to $70B, but operating income was down and margins for AWS and North America contracted. In terms of cloud Microsoft Azure grew 59% YoY in the previous quarter. Microsoft is definitely catching up, and there might be …

Chr. Hansen and Novozymes both tumble

The two Danish enzyme manufacturers Chr. Hansen and Novozymes both saw their share price tumble following third quarter earnings. Chr. Hansen released earnings on October 10th and Novozymes released earnings on October 23nd. This followed the October 9th profit warning from Novozymes. Chr. Hansen, which traded and continues to trade at higher multiples, fell from …

Microsoft Cloud Strength Drives First Quarter Results

Microsoft issued a press release on its 2020 first quarter results after the markets closed with the following bullet points. Revenue was $33.1 billion and increased 14% Operating income was $12.7 billion and increased 27% Net income was $10.7 billion and increased 21% Diluted earnings per share was $1.38 and increased 21% The figures below …

P&G raises 2020 guidance amidst shining beauty and trimmed grooming

Procter & Gamble [$PG] issued a press release on its first quarter results prior to the market opening. The company raised its full year guidance. The share price jumped by 2.6% from $119.08 to a 52 week high of $122.18. Financials All segments except grooming displayed positive organic sales growth. The main contributors to top …

Bank OZK misses revenue and earnings estimates

Bank OZK [$OZK] issued a press release after the closing bell on its quarterly results accompanied by the following comment from the CEO George Gleason. “We are very pleased to have once again delivered financial metrics among the best in the industry for the quarter just ended.  We continue to maintain our focus on our …

Netflix beats on profit but misses on number of new subscribers

Netflix issued a press release on its quarterly results after the closing bell. In Q3, we grew to $5.2 billion in revenue, up 31% over the prior year, and operating income doubled to$1.0 billion. Paid net adds totaled 6.8m compared to our 7.0m forecast and prior year Q3 of 6.1m. As we’ve improved the variety, …